SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
QTTB

Q32 Bio Inc. (NASDAQ:QTTB)

US · Delayed Price · Currency is USD
Also listed: 0T6G.LHealthcare · Biotechnology
$8.34-$0.14 (-1.65%)
 
Market cap
$250M
Insider Score
Health Score
Analyst consensus
Listed since
Mar 28, 2018
Website
Market Cap$249.57M+317.0%
Revenue (ttm)$53.74M
Net Income$32.25M+176.6%
EPS$3.13+162.1%
Shares Out29.92M
PE Ratio2.66
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume476,717
Open$8.37
Previous Close$8.48
Day's Range$8.22 - $8.57
52-Week Range$1.98 - $23.57
Betan/a
AnalystsBuy
Price Target$36.50(+337.65%)
Earnings DateMar 9, 2027

About QTTB

Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to developing biologic therapies aimed at re-establishing healthy immune equilibrium in patients across the United States suffering from autoimmune and inflammatory disorders stemming from dysfunctional immune responses. The company's primary investigational therapy, ADX-097, is a humanized anti-C3d monoclonal antibody fusion protein designed to normalize complement regulation. This candidate has successfully finished its Phase I clinical trial, targeting severe renal and other complement-driven conditions where patient needs are largely unmet, such as lupus nephritis, IgA nephropathy, C3 glomerulopathy, and ANCA-associated vasculitis. Additionally, Q32 Bio is advancing Bempikibart (ADX-914), a fully human monoclonal antibody antagonist against interleukin-7 receptor alpha. Currently in Phase II trials, Bempikibart aims to recalibrate adaptive immune responses by inhibiting signaling pathways involving interleukin-7 and thymic stromal lymphopoietin, offering potential treatment for atopic dermatitis and alopecia areata. Founded in 2017 and headquartered in Waltham, Massachusetts, Q32 Bio Inc. adopted its current name in April 2020, having previously operated as AdMIRx Inc.

Address
830 Winter Street, Waltham, MA, 02451, US
Market Cap
250 million
Employees
22
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$505.00K
Bought
$30.00M

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Sound
From QTTB’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-1.65%
5 Days
-3.70%
1 Month
-3.81%
6 Months
+51.64%
1 Year
+317.00%

$QTTB stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in QTTB holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by QTTB's directors and management

Net Shares Purchased by Insiders−4M−2M02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

QTTB Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New QTTB patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to QTTB from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in QTTB

VTIVanguard Morningstar Total Stock Market ETF$5.30M
AVUVAvantis U.S. Small Cap Value ETF$4.48M
VXFVanguard Extended Market ETF$2.07M
FDMFirst Trust Dow Jones Select MicroCap Index Fund$746.67K
DFASDimensional - US Small Cap ETF$346.81K
AVSCAvantis U.S. Small Cap Equity ETF$293.31K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from QTTB’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
28.28
Analyst Ratings
40% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
4
Sells
11
Buy Value
$30.00M
Distinct Buyers
2

Insider Score Trend Over Time

-36.0 since Aug 28
0255075100Aug 28 — Insider Score 36.0Aug 29 — Insider Score 36.0Aug 30 — Insider Score 36.0Aug 31 — Insider Score 36.0Sep 1 — Insider Score 0.0Sep 2 — Insider Score 0.0Sep 3 — Insider Score 0.0Sep 4 — Insider Score 0.0Sep 5 — Insider Score 0.0Sep 6 — Insider Score 0.0Sep 7 — Insider Score 0.0Sep 8 — Insider Score 0.0Sep 9 — Insider Score 0.0Sep 10 — Insider Score 0.0Sep 11 — Insider Score 0.0Sep 12 — Insider Score 0.0Sep 13 — Insider Score 0.0Sep 14 — Insider Score 0.0Sep 15 — Insider Score 0.0Sep 16 — Insider Score 0.0Sep 17 — Insider Score 0.0Sep 18 — Insider Score 0.0Sep 19 — Insider Score 0.0Sep 20 — Insider Score 0.0Sep 21 — Insider Score 0.0Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 28.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Aug 28Sep 15Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

QQQSInvesco NASDAQ Future Gen 200 ETF0.35%
FDMFirst Trust Dow Jones Select MicroCap Index Fund0.29%
ROSCHartford Multifactor Small Cap ETF0.23%
TNXTT. Rowe Price Innovation Leaders ETF0.05%

Weight is the stock’s share of each fund’s holdings.